Menu Search
Equities

Curaleaf Holdings Inc

CURA:TOR

Curaleaf Holdings Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CAD)3.10
  • Today's Change-0.05 / -1.59%
  • Shares traded689.62k
  • 1 Year change-30.49%
  • Beta1.3900
Data delayed at least 15 minutes, as of Nov 14 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Curaleaf Holdings Inc grew revenues 5.58% from 1.28bn to 1.35bn while net income improved from a loss of 370.10m to a smaller loss of 281.20m.
Gross margin47.02%
Net profit margin-15.12%
Operating margin0.04%
Return on assets-6.51%
Return on equity-19.21%
Return on investment-8.01%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Curaleaf Holdings Inc fell by 71.36m. However, the company earned 75.26m from its operations for a Cash Flow Margin of 5.59%. In addition the company used 78.69m on investing activities and also paid 67.02m in financing cash flows.
Cash flow per share0.0117
Price/Cash flow per share272.05
Book value per share1.80
Tangible book value per share-1.51
More ▼

Balance sheet in USDView more

Curaleaf Holdings Inc has a Debt to Total Capital ratio of 46.23%, a lower figure than the previous year's 80.98%.
Current ratio1.11
Quick ratio0.5143
Total debt/total equity0.9725
Total debt/total capital0.4623
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.